Durvalumab vs Sumatriptan

Durvalumab vs Sumatriptan: Overview

This comparison examines the pharmacological differences between Durvalumab and Sumatriptan.

Mechanism of Action

Durvalumab: Human IgG1 kappa anti-PD-L1 monoclonal antibody blocking PD-L1 binding to PD-1 and CD80.

Sumatriptan: Selective 5-HT1B/1D receptor agonist.

Pharmacokinetics

Half-life: Durvalumab — 17 days; Sumatriptan — 2.5 hours.

Chemical Properties

Molecular Formula: Sumatriptan — C14H21N3O2S.

Molecular Weight: Sumatriptan — 295.4020 g/mol.

Type: Durvalumab — Antibody; Sumatriptan — Small molecule.